General Information of Drug (ID: DMXCD69)

Drug Name
CEP1347 Drug Info
Synonyms AC1L31ZX; SCHEMBL1649555; ZINC103589452; DB05403
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 2/3 [1]
Cross-matching ID
PubChem CID
9917013
CAS Number
CAS 156177-65-0
TTD Drug ID
DMXCD69

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
URMC-099 DMCJXWK Discovery agent N.A. Investigative [3]
CEP-5104 DMV43GY Discovery agent N.A. Investigative [4]
CEP-6331 DMNXBTD Discovery agent N.A. Investigative [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mixed lineage kinase 1 (MAP3K9) TTUNSIX M3K9_HUMAN Inhibitor [2]

References

1 Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy. Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):63-7.
2 Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5.
3 Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. J Med Chem. 2013 Oct 24;56(20):8032-48.
4 Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-linea... J Med Chem. 2008 Sep 25;51(18):5680-9.